Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$38.19 - $57.45 $126,561 - $190,389
3,314 Added 122.29%
6,024 $232,000
Q3 2022

Nov 14, 2022

BUY
$51.24 - $58.89 $4,970 - $5,712
97 Added 3.71%
2,710 $144,000
Q2 2022

Aug 15, 2022

BUY
$51.49 - $81.64 $14,417 - $22,859
280 Added 12.0%
2,613 $152,000
Q1 2022

Aug 15, 2022

BUY
$60.03 - $76.49 $62,551 - $79,702
1,042 Added 80.71%
2,333 $178,000
Q3 2021

Nov 10, 2021

BUY
$54.64 - $61.3 $34,860 - $39,109
638 Added 97.7%
1,291 $72,000
Q2 2021

Aug 11, 2021

BUY
$59.18 - $69.99 $38,644 - $45,703
653 New
653 $40,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $1.06B
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Heritage Wealth Management, LLC Portfolio

Follow Heritage Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heritage Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Heritage Wealth Management, LLC with notifications on news.